1999 Journal Article Prognostic significance of tumor angiogenesis in epithelial ovarian cancerObermair, A, Wasicky, R, Kaider, A, Preyer, O, Losch, A, Leodolter, S and Kolbl, H (1999). Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. Cancer Letters, 138 (1-2), 175-182. doi: 10.1016/S0304-3835(99)00005-1 |
1999 Journal Article Impact of angiogenesis in gynecology and obstetricsObermair, A, Preyer, O and Leodolter, S (1999). Impact of angiogenesis in gynecology and obstetrics. Wiener Klinische Wochenschrift, 111 (7), 262-277. |
1999 Journal Article Prognostic significance of tumor angiogenesis in endometrial cancerObermair, A, Tempfer, C, Wasicky, R, Kaider, A, Hefler, L and Kainz, C (1999). Prognostic significance of tumor angiogenesis in endometrial cancer. Obstetrics and Gynecology, 93 (3), 367-371. doi: 10.1016/S0029-7844(98)00417-7 |
1999 Journal Article Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral bloodStimpfl, M, Schmid, BC, Obermair, A, Tong, D, Schiebel, I, Gitsch, G, Leodolter, S and Zeillinger, R (1999). Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood. Oncology Research, 11 (8), 367-373. |
1998 Journal Article Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatinObermair, A, Speiser, P, Thoma, M, Kaider, A, Salzer, H, Dittrich, C and Sevelda, P (1998). Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin. International Journal of Oncology, 13 (5), 1023-1030. |
1998 Journal Article Epidemiologic considerations on the significance of hormones in carcinogenesisObermair, A, Jirecek, S and Leodolter, S (1998). Epidemiologic considerations on the significance of hormones in carcinogenesis. Gynakologisch-Geburtshilfliche Rundschau, 38 (2), 73-79. doi: 10.1159/000022235 |
1998 Journal Article p53 protein overexpression: A strong prognostic factor in uterine papillary serous carcinomaBancher-Todesca, D, Gitsch, G, Williams, KE, Kohlberger, P, Neunteufel, W, Obermair, A, Heinze, G, Breitenecker, G and Hacker, NF (1998). p53 protein overexpression: A strong prognostic factor in uterine papillary serous carcinoma. Gynecologic Oncology, 71 (1), 59-63. doi: 10.1006/gyno.1998.5113 |
1998 Journal Article Vascular endothelial growth factor serum concentrations in ovarian cancerTempfer, C, Obermair, A, Hefler, L, Haeusler, G, Gitsch, G and Kainz, C (1998). Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstetrics and Gynecology, 92 (3), 360-363. doi: 10.1016/S0029-7844(98)00190-2 |
1998 Journal Article The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patientsObermair, Andreas, Handisurya, Alessandra, Kaider, Alexandra, Sevelda, Paul, Kölbl, Heinz and Gitsch, Gerald (1998). The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients. Cancer, 83 (4), 726-731. doi: 10.1002/(sici)1097-0142(19980815)83:43.3.co;2-g |
1998 Conference Publication The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients - A prospective reviewObermair, A, Handisurya, A, Kaider, A, Sevelda, P, Kolbl, H and Gitsch, G (1998). The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients - A prospective review. 10th Annual Meeting of European-Society-of-Gynaecological-Oncology, Coimbra Portugal, Apr 26-May 02, 1997. doi: 10.1002/(SICI)1097-0142(19980815)83:43.0.CO;2-U |
1998 Journal Article Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patientsObermair, A, Speiser, P, Reisenberger, K, Ullrich, R, Czerwenka, K, Kaider, A, Zeillinger, R and Miksche, M (1998). Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Letters, 130 (1-2), 69-76. doi: 10.1016/S0304-3835(98)00119-0 |
1998 Journal Article Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancerObermair, A., Tempfer, C., Hefler, L., Preyer, O., Kaider, A., Zeillinger, R., Leodolter, S. and Kainz, C. (1998). Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer. British Journal of Cancer, 77 (11), 1870-1874. doi: 10.1038/bjc.1998.311 |
1998 Journal Article Onycholysis in patients treated with docetaxelObermair, A, Binder, M, Barrada, M, Bancher-Todesca, D, Asseryanis, E and Kubista, E (1998). Onycholysis in patients treated with docetaxel. Annals of Oncology, 9 (2), 230-231. doi: 10.1023/A:1008218824342 |
1998 Journal Article The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma - Correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigenObermair, A, Wanner, C, Bilgi, S, Speiser, P, Reisenberger, K, Kaider, A, Kainz, C, Leodolter, S, Breitenecker, G and Gitsch, G (1998). The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma - Correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen. Cancer, 82 (4), 689-696. doi: 10.1002/(SICI)1097-0142(19980215)82:43.0.CO;2-U |
1998 Journal Article Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survivalObermair, A, Wanner, C, Bilgi, S, Speiser, P, Kaider, A, Reinthaller, A, Leodolter, S and Gitsch, G (1998). Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival. American Journal of Obstetrics and Gynecology, 178 (2), 314-319. doi: 10.1016/S0002-9378(98)80018-5 |
1998 Journal Article Color-coded and spectral Doppler flow in breast carcinomas - Relationship with the tumor microvasculaturePeters-Engl, C, Medl, M, Mirau, M, Wanner, C, Bilgi, S, Sevelda, P and Obermair, A (1998). Color-coded and spectral Doppler flow in breast carcinomas - Relationship with the tumor microvasculature. Breast Cancer Research and Treatment, 47 (1), 83-89. doi: 10.1023/A:1005992916193 |
1998 Conference Publication Prognostic impact of microvessel density in stage IB carcinoma of the uterine cervixObermair, A, Wanner, C, Bilgi, S, Speiser, P, Kaider, A, Reinthaller, A, Leodolter, S and Gitsch, G (1998). Prognostic impact of microvessel density in stage IB carcinoma of the uterine cervix. DORDRECHT: KLUWER ACADEMIC PUBL. |
1997 Journal Article Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survivalObermair, A, Kucera, E, Mayerhofer, K, Speiser, P, Seifert, M, Czerwenka, K, Kaider, A, Leodolter, S, Kainz, C and Zeillinger, R (1997). Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival. International Journal of Cancer, 74 (4), 455-458. doi: 10.1002/(SICI)1097-0215(19970822)74:43.0.CO;2-8 |
1997 Journal Article Management of incomplete resected cervical neoplasia after LLETZ-conization Management unvollstandig entfernter Lasionen nach SchlingenkonisationBancher-Todesca, D., Obermair, A., Zeisler, H., Prainsack, D., Gitsch, G. and Reinthaller, A. (1997). Management of incomplete resected cervical neoplasia after LLETZ-conization Management unvollstandig entfernter Lasionen nach Schlingenkonisation. Geburtshilfe und Frauenheilkunde, 57 (8), 458-462. |
1997 Journal Article Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasiaObermair, A, BancherTodesca, D, Bilgi, S, Kaider, A, Kohlberger, P, MullauerErtl, S, Leodolter, S and Gitsch, G (1997). Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. Journal of the National Cancer Institute, 89 (16), 1212-1217. doi: 10.1093/jnci/89.16.1212 |